Do Immune-Based Cancer Drugs Work Better in Men?
FRIDAY, Dec. 3, 2021 (HealthDay News) — Women are two times more likely than men to die after receiving a combination of cancer immunotherapy drugs called checkpoint inhibitors, but it’s not clear if that difference is due to side effects or because the treatment isn’t working, researchers say. This newContinue Reading